Diazoxide Choline Controlled-Release Tablet

DRUG3 trials

Sponsors

Essentialis, Inc.

Conditions

DyslipidemiaHypertriglyceridemiaHypertriglyceridmiaPrader-Willi Syndrome

Phase 1

Pharmacokinetic Study of Diazoxide Choline in Hypertriglyeridemic Subjects

CompletedNCT01211860

Essentialis, Inc.Hypertriglyceridmia

Start: 2010-10-31End: 2010-11-30Updated: 2014-01-10

Phase 2

Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia

CompletedNCT01211847

Essentialis, Inc.Dyslipidemia, Hypertriglyceridemia

Start: 2010-10-31End: 2011-12-31Updated: 2014-01-10

A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)

Essentialis, Inc.Prader-Willi Syndrome

Start: 2017-07-31End: 2017-12-31Target: 32Updated: 2016-09-09